Recombinant Mycobacterium tuberculosis ESAT6 protein

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The ESAT-6 protein also known as Early Secretory Antigenic Target 6 kDa is a small highly conserved protein found in Mycobacterium tuberculosis with a molecular mass of approximately 6 kDa. It is secreted by the bacterium and plays a significant role in its pathogenicity. ESAT-6 is expressed strongly during infection particularly within the host macrophages. Its ability to modulate host immune responses makes it an important molecule in tuberculosis research and diagnostics.

Biological function summary

ESAT-6 interacts with the host cell's membranes promoting virulence by disrupting immune functions. It does not act alone but forms a complex with the CFP-10 protein which is essential for its stability and secretion. This complex enables ESAT-6 to interfere with immune recognition helping Mycobacterium tuberculosis evade host defenses. These interactions make ESAT-6 a target of protein assays and a focal point in the study of mycobacterium-host interactions.

Pathways

ESAT-6 interferes with immune response pathways particularly the path leading to cell-mediated immunity. It directly affects the NF-kB pathway a critical regulator of immune response by destabilizing macrophage lysosomal membranes. The activity of ESAT-6 connects with another protein PhoP involved in regulating virulent gene expression in Mycobacterium tuberculosis. This interaction disrupts normal cellular signaling aiding in bacterial survival within the host.

ESAT-6 plays a pivotal role in the pathogenesis of tuberculosis a major infectious disease worldwide. The protein's role in attenuating immune responses makes it vital for the persistence of Mycobacterium tuberculosis within the host. Additionally ESAT-6 has connections to other disorders like granuloma formation which results from chronic infections. In tuberculosis the interplay between ESAT-6 and the Rv3879c antigen another virulence factor impacts granuloma development making it a target for therapeutic interventions aimed at combating tuberculosis.